# KB-S53 — Wave C classification and unblock audit

**work_id:** KB-S53  
**Audit date:** 2026-03-31  
**Classification:** Read-only CONTENT audit (single markdown deliverable per sprint prompt).  
**Authority for Wave C membership:** `knowledge_bus/governance/translation_contract_v3_to_package_KB-S52B_v1.yaml` → `readiness_waves_spec_ids.wave_c_blocked_prerequisite.spec_ids` (46 specs).  
**Primary blocker register:** `knowledge_bus/research/KB-S52A_PREFLIGHT_AUDIT_Batches_3-7_Pass3.md` §3–4 (resolver summary + per-spec outcomes).  
**Remap / deferral context:** `knowledge_bus/governance/translation_remap_contract_KB-S52B_v1.yaml` (APPROVED / DEFERRED / `out_of_scope_for_remap_table`).  
**Non-analyte taxonomy (adopted):** `translation_contract_v3_to_package_KB-S52B_v1.yaml` → `non_analyte_reference_classes` (NA-PROCEDURE, NA-GENETIC_SPECIALIST, NA-MORPHOLOGY, NA-LOGICAL_REPEAT).

---

## Executive summary

| Metric | Value |
|--------|------:|
| Wave C specs (authoritative list) | **46** |
| All specs BLOCKED in KB-S52A §4 | **46** (100%) |
| PTH-family + phosphate stack (calcium / corrected calcium / vitamin D cohorts) | **10** specs with `parathyroid_hormone` / `pth` / `pth_related_peptide` per KB-S52A §4; **3** additional ALP specs add `phosphate` without PTH |
| Dominant theme: `lym` abbreviation / compound differential specs | **6** (primary `lym` unmapped ×2; `neutrophils`/`wbc` specs with supporting `lym` ×4) |
| Dominant theme: derived / panel constructs (`transferrin_saturation`, acid–base pair, renal Mg indices, `rbc_count`, `amylase`, reticulocyte indices) | **~18 specs** |
| Non-analyte / procedure / morphology / logical-repeat markers per KB-S52B NA classes | **4** specs (SPE ×2; smudge_cells; repeat_bilirubin) |
| Mixed compound: **approved** remap token + **non-remap** prerequisite | **1** (`inv_hba1c_pct_low_*`: `fasting_glucose` + `reticulocyte_count`) |

**Risk overview**

- A large share of Wave C is addressable as **CONTENT / STANDARD** work if scoped as **SSOT expansion**, **derived-metric / ratio registry** rows, and governed **non-analyte** handling—without changing investigation_spec v3.0.0.
- Specs involving **`contradiction_markers`** with NA-LOGICAL_REPEAT (`repeat_bilirubin`) and promoted-signal translation are **MIXED / HIGH** until `signal_intelligence_translation_rules_v1.yaml` + translator behaviour explicitly cover contradiction aggregation for non-analyte refs (per KB-S52B notes).
- Any sprint that changes **Intelligence Core** translation or validators (not in scope for KB-S53) remains **BEHAVIOUR / HIGH** by SOP.

**Recommended tranche split:** plan **at least four** bounded follow-on sprints (not “ingest all Wave C”):

1. **PTH / calcium / phosphate / vitamin D stack** — SSOT canons + alias governance for `pth`, `parathyroid_hormone`, `pth_related_peptide`, `phosphate` (with coordinated `corrected_calcium` + `calcium` specs).  
2. **`lym` disambiguation + dependent differentials** — resolve DEFERRED `lym` per remap contract, then ingest `neutrophils` / `wbc` specs that only need supporting `lym` after disambiguation.  
3. **Derived metrics and iron / renal / CBC adjuncts** — `transferrin_saturation`, acid–base (`bicarbonate`, `anion_gap`), Mg excretion markers, `rbc_count`, reticulocyte indices, `amylase`, `procalcitonin`, `erythropoietin`, `vitamin_b6`, `mma`, `igg`, `urine_protein_creatinine_ratio`, etc., per `out_of_scope_for_remap_table`.  
4. **Non-analyte / procedure / morphology / logical-repeat policy** — SPE, `jak2_v617f`, `smudge_cells`, `repeat_bilirubin` with explicit NA- class handling and translator guards.

---

## 1. Blocker taxonomy (Wave C aggregate)

Categories are **not** mutually exclusive per spec; counts below are **specs with at least one touchpoint** in that category (some specs appear in multiple categories).

| Blocker category (named) | Approx. specs | Representative upstream tokens / notes |
|--------------------------|--------------:|----------------------------------------|
| Missing canonical SSOT biomarker (PTH family) | 10 | `parathyroid_hormone`, `pth`, `pth_related_peptide` (DEFERRED in remap contract); appears on calcium, corrected calcium, vitamin D specs |
| Missing / prerequisite registry token (`phosphate`, etc.) | 8 | `phosphate` in ALP + calcium / corrected calcium stacks (`out_of_scope_for_remap_table`) |
| Alias / naming ambiguity (`lym`) | 6 | Primary unmapped `lym` ×2; supporting `lym` on neutrophil/WBC ×4 (remap contract: DEFERRED `ambiguous_abbreviation`) |
| Unsupported derived metric / ratio / renal construct | 14 | `transferrin_saturation`, `bicarbonate`, `anion_gap`, `fractional_excretion_magnesium`, `urine_magnesium_24h`, `urine_protein_creatinine_ratio`, `rbc_count`, `amylase` |
| Reticulocyte / marrow response indices | 3 | `reticulocytes`, `reticulocyte_count` |
| Specialist / immunology / acute-phase adjunction | 6 | `mma`, `total_b12`, `igg`, `procalcitonin`, `erythropoietin`, `vitamin_b6` |
| Unsupported non-analyte / procedure / morphology / logical-repeat | 4 | `serum_protein_electrophoresis` (NA-PROCEDURE), `smudge_cells` (NA-MORPHOLOGY), `repeat_bilirubin` (NA-LOGICAL_REPEAT), `jak2_v617f` (NA-GENETIC_SPECIALIST) |
| Mixed compound: approved remap scope + extra prerequisite | 1 | `fasting_glucose` (APPROVED remap) + `reticulocyte_count` (out of scope) on `inv_hba1c_pct_low_*` |

**Translation-boundary note (cross-cutting):** KB-S52A §5 documents batch-array vs single-object validator shape and promoted-signal depth — **cautionary** for ingestion tooling, not a per-spec “blocker class” in this table.

---

## 2. Follow-on sprint proposal (smallest safe sequence)

Order respects “insert bounded maturity work before breadth expansion” (prompt strategic context).

| Seq | Sprint theme | Scope (blocker classes) | Expected dominant risk |
|----|--------------|-------------------------|-------------------------|
| **S1** | **PTH / mineral / vitamin D SSOT tranche** | Missing SSOT for PTH tokens; phosphate prerequisites; vitamin D specs using `parathyroid_hormone` | CONTENT / STANDARD (SSOT + governance); verify no translator change required for pure alias/canonical adds |
| **S2** | **`lym` resolution + differential clean-up** | DEFERRED `lym`; dependent `neutrophils` / `wbc` specs | CONTENT / STANDARD if disambiguation is pure remap + SSOT key choice; MIXED if differential semantics require Intelligence Core changes |
| **S3** | **Derived-metric / iron / renal / lipase / reticulocyte tranche** | `transferrin_saturation`, acid–base indices, Mg excretion, UPCR, `rbc_count`, `amylase`, reticulocyte counts | MIXED if engine computes derived values; else CONTENT if SSOT-only |
| **S4** | **Non-analyte / procedure / morphology / logical-repeat tranche** | NA-PROCEDURE, NA-GENETIC_SPECIALIST, NA-MORPHOLOGY, NA-LOGICAL_REPEAT | MIXED / HIGH where `contradiction_markers` or promotion paths need translator guards (e.g. `repeat_bilirubin` per KB-S52B) |
| **S5** (optional carve-out) | **Active B12 / functional B12 stack** | `mma`, `total_b12` contradiction / override touchpoints | CONTENT for SSOT rows; MIXED if override rule reduction touches pipeline |

No sprint above is “ingest all Wave C”; each tranche should exit with **measurable resolver clearance** for its token subset before the next.

---

## 3. Selective regeneration assessment (default: preserve)

Per prompt: **default bias = preserve** Pass 3 `inv_*` artifacts unless selective regeneration is clearly cheaper.

| Assessment | Count | Specs (summary) |
|------------|------:|-----------------|
| **Preserve** `inv_*` and unblock structurally | 44 | All specs where blockers are registry / SSOT / derived-metric / NA-class policy — structural unlock is the expected path |
| **Selective regeneration** *may* be cheaper | 0 | None identified in KB-S53: upstream narrative is not the driver; touchpoints are resolver/construct gaps |
| **Unclear / needs medical+contract review** | 2 | `inv_lym_*` — clinical disambiguation between percent vs absolute lymphocyte constructs must be decided before remap; `inv_globulin_low_*` — dual touchpoint (`igg` + UPCR) may need ordering of SSOT vs renal-ratio work |

---

## 4. Full Wave C inventory (46 specs)

**Columns:** source batch (Pass 3 JSON), `spec_id`, `signal_id`, primary `biomarker_id` (from `primary_marker` in source), KB-S52A unmapped touchpoint summary, **blocker class**, **blocker location**, **unblock path**, **eventual fix risk**, **regeneration**.

| Batch file | spec_id | signal_id | Primary biomarker | Unmapped / blocker touchpoints (KB-S52A §4) | Blocker class | Blocker location | Recommended unblock path | Eventual fix risk | Regeneration |
|------------|---------|-----------|-------------------|---------------------------------------------|---------------|------------------|--------------------------|-------------------|--------------|
| Batch_5_Pass_3.json | inv_active_b12_low_b12_depletion | signal_active_b12_low | active_b12 | `mma` (KB-S52A §4); source also references `total_b12` in contradictions — **not** listed as unmapped in KB-S52A (resolver-clean for that pass) | Unsupported specialist / functional prerequisite (`mma` in `out_of_scope_for_remap_table`) | supporting_markers; override_rules (`metric_id: mma`) | SSOT / engine support for MMA (+ confirm `total_b12` remains resolver-clean on ingest) | MIXED / HIGH if override rule reduction touches pipeline | Preserve |
| Batch_5_Pass_3.json | inv_alp_high_high_bone_turnover_pattern | signal_alp_high | alp | `phosphate` | Missing / prerequisite registry token | supporting_markers | SSOT / registry row for `phosphate` (with derived handling if needed) | CONTENT / STANDARD | Preserve |
| Batch_5_Pass_3.json | inv_alp_low_hypophosphatasia_pattern | signal_alp_low | alp | `phosphate`, `vitamin_b6` | Missing prerequisite tokens | supporting_markers | SSOT expansion for phosphate + B6 | CONTENT / STANDARD | Preserve |
| Batch_5_Pass_3.json | inv_alp_low_nutrient_or_cofactor_deficiency | signal_alp_low | alp | `vitamin_b6` | Missing canonical / specialist marker | supporting_markers | SSOT expansion for `vitamin_b6` | CONTENT / STANDARD | Preserve |
| Batch_5_Pass_3.json | inv_bilirubin_high_gilbert_pattern | signal_bilirubin_high | bilirubin | `repeat_bilirubin` (contradiction) | Unsupported non-analyte reference (NA-LOGICAL_REPEAT) | contradiction_markers | Non-analyte policy + translator guard for contradiction aggregation | MIXED / HIGH | Preserve |
| Batch_5_Pass_3.json | inv_bilirubin_high_hemolytic_turnover_pattern | signal_bilirubin_high | bilirubin | `reticulocytes` | Unsupported derived / registry prerequisite | supporting_markers | Add `reticulocytes` (or equivalent) to SSOT + promotion rules | CONTENT / STANDARD | Preserve |
| Batch_5_Pass_3.json | inv_calcium_high_primary_hyperparathyroid_pattern | signal_calcium_high | calcium | `parathyroid_hormone`, `phosphate`, `pth_related_peptide` | Missing SSOT PTH + specialist peptide + phosphate | supporting_markers | S1 stack: PTH canons + `pth_related_peptide` policy + phosphate | MIXED / HIGH if peptide semantics need core translation | Preserve |
| Batch_5_Pass_3.json | inv_calcium_high_pth_independent_hypercalcemia | signal_calcium_high | calcium | `parathyroid_hormone`, `pth_related_peptide` | Missing SSOT PTH family | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_5_Pass_3.json | inv_calcium_low_hypoparathyroid_pattern | signal_calcium_low | calcium | `parathyroid_hormone`, `phosphate` | Missing SSOT PTH + phosphate | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_5_Pass_3.json | inv_calcium_low_vitamin_d_or_magnesium_related_hypocalcemia | signal_calcium_low | calcium | `parathyroid_hormone` | Missing SSOT PTH | supporting_markers | S1 stack | CONTENT / STANDARD | Preserve |
| Batch_6_Pass_3.json | inv_chloride_high_hyperchloremic_metabolic_acidosis | signal_chloride_high | chloride | `bicarbonate`, `anion_gap` | Unsupported derived metric / acid–base construct | supporting_markers | Derived-metric definitions + engine support or SSOT equivalents | MIXED / HIGH if computed | Preserve |
| Batch_6_Pass_3.json | inv_chloride_low_chloride_depletion_metabolic_alkalosis | signal_chloride_low | chloride | `bicarbonate` | Unsupported derived metric | supporting_markers | S3 acid–base tranche | MIXED / HIGH if computed | Preserve |
| Batch_6_Pass_3.json | inv_corrected_calcium_high_malignancy_mediated_hypercalcemia | signal_corrected_calcium_high | corrected_calcium | `pth`, `phosphate` | Missing SSOT `pth` + phosphate | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_6_Pass_3.json | inv_corrected_calcium_high_pth_mediated_hypercalcemia | signal_corrected_calcium_high | corrected_calcium | `pth`, `phosphate` | Missing SSOT `pth` + phosphate | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_6_Pass_3.json | inv_corrected_calcium_low_hypoparathyroid_state | signal_corrected_calcium_low | corrected_calcium | `pth`, `phosphate` | Missing SSOT `pth` + phosphate | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_6_Pass_3.json | inv_corrected_calcium_low_secondary_hyperparathyroid_context | signal_corrected_calcium_low | corrected_calcium | `pth`, `phosphate` | Missing SSOT `pth` + phosphate | supporting_markers | S1 stack | MIXED / HIGH | Preserve |
| Batch_4_Pass_3.json | inv_crp_high_active_inflammatory_or_infective_state | signal_crp_high | crp | `procalcitonin` | Unsupported specialist / acute-phase marker | supporting_markers | SSOT expansion for procalcitonin | CONTENT / STANDARD | Preserve |
| Batch_4_Pass_3.json | inv_crp_high_residual_cardiometabolic_inflammatory_risk | signal_crp_high | crp | `procalcitonin` | Unsupported specialist marker | supporting_markers | SSOT expansion | CONTENT / STANDARD | Preserve |
| Batch_4_Pass_3.json | inv_ferritin_high_inflammatory_hyperferritinemia | signal_ferritin_high | ferritin | `transferrin_saturation` | Unsupported derived / ratio construct | supporting_markers | S3 iron indices tranche | MIXED / HIGH if ratio | Preserve |
| Batch_4_Pass_3.json | inv_ferritin_high_iron_overload_context | signal_ferritin_high | ferritin | `transferrin_saturation` | Unsupported derived / ratio construct | supporting_markers | S3 | MIXED / HIGH if ratio | Preserve |
| Batch_3_Pass_3.json | inv_globulin_high_monoclonal_gammopathy_signal | signal_globulin_high | globulin | `serum_protein_electrophoresis` | Unsupported non-analyte / procedure (NA-PROCEDURE) | supporting_markers | NA-class SSOT/policy + translation | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_globulin_high_polyclonal_inflammatory_hypergammaglobulinemia | signal_globulin_high | globulin | `serum_protein_electrophoresis` | NA-PROCEDURE | supporting_markers | S4 non-analyte tranche | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_globulin_low_hypogammaglobulinemia_or_protein_loss | signal_globulin_low | globulin | `igg`, `urine_protein_creatinine_ratio` | Specialist marker + renal ratio construct | supporting_markers | SSOT for `igg`; derived/SSOT for UPCR | MIXED / HIGH | Unclear (ordering) |
| Batch_3_Pass_3.json | inv_hba1c_pct_low_shortened_red_cell_survival_or_low_glycemia | signal_hba1c_pct_low | hba1c_pct | `fasting_glucose`, `reticulocyte_count` | Mixed: approved remap token + out-of-scope retic index | supporting_markers | Apply APPROVED `fasting_glucose→glucose`; add `reticulocyte_count` prerequisite | CONTENT / STANDARD for remap; MIXED if derived engine | Preserve |
| Batch_3_Pass_3.json | inv_hematocrit_high_absolute_erythrocytosis | signal_hematocrit_high | hematocrit | `erythropoietin`, `jak2_v617f` | Specialist hormone + genetic/specialist marker | supporting_markers | SSOT for EPO; NA-GENETIC_SPECIALIST policy for JAK2 | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_hematocrit_high_relative_hemoconcentration | signal_hematocrit_high | hematocrit | `erythropoietin` | Specialist marker | supporting_markers | SSOT expansion | CONTENT / STANDARD | Preserve |
| Batch_6_Pass_3.json | inv_hgb_high_erythrocytosis_or_hypoxic_drive | signal_hgb_high | hgb | `erythropoietin` | Specialist marker | supporting_markers | SSOT expansion | CONTENT / STANDARD | Preserve |
| Batch_6_Pass_3.json | inv_hgb_low_iron_deficiency_or_blood_loss_anemia | signal_hgb_low | hgb | `reticulocytes` | Registry / marrow-response marker | supporting_markers | SSOT + promotion path for reticulocytes | CONTENT / STANDARD | Preserve |
| Batch_3_Pass_3.json | inv_iron_high_hepatocellular_or_hemolytic_release | signal_iron_high | iron | `transferrin_saturation` | Derived / ratio construct | supporting_markers | S3 | MIXED / HIGH if ratio | Preserve |
| Batch_3_Pass_3.json | inv_iron_high_iron_overload_context | signal_iron_high | iron | `transferrin_saturation` | Derived / ratio | supporting_markers | S3 | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_iron_low_absolute_iron_deficiency | signal_iron_low | iron | `transferrin_saturation` | Derived / ratio | supporting_markers | S3 | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_iron_low_functional_iron_restriction_inflammation | signal_iron_low | iron | `transferrin_saturation` | Derived / ratio | supporting_markers | S3 | MIXED / HIGH | Preserve |
| Batch_6_Pass_3.json | inv_lym_high_reactive_or_lymphoproliferative_lymphocytosis | signal_lym_high | lym | primary `lym` **UNMAPPED**; `wbc_total` (APPROVED remap to `white_blood_cells`) | Alias ambiguity + compound approved remap | **primary** biomarker; supporting_markers | Disambiguate `lym`; apply `wbc_total` remap per contract | MIXED / HIGH until disambiguation locked | Unclear |
| Batch_6_Pass_3.json | inv_lym_low_lymphopenia_stress_or_immunosuppression | signal_lym_low | lym | primary `lym` **UNMAPPED**; `wbc_total` | Alias ambiguity + compound remap | **primary** biomarker; supporting_markers | S2 | MIXED / HIGH until disambiguation locked | Unclear |
| Batch_3_Pass_3.json | inv_lymphocytes_abs_high_reactive_lymphocytosis | signal_lymphocytes_abs_high | lymphocytes_abs | `smudge_cells` | Unsupported non-analyte morphology (NA-MORPHOLOGY) | supporting_markers | S4 morphology policy | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_lymphocytes_abs_low_true_lymphopenia | signal_lymphocytes_abs_low | lymphocytes_abs | `igg` | Specialist immunology marker | supporting_markers | SSOT expansion | CONTENT / STANDARD | Preserve |
| Batch_3_Pass_3.json | inv_magnesium_low_renal_magnesium_wasting | signal_magnesium_low | magnesium | `fractional_excretion_magnesium`, `urine_magnesium_24h` | Derived / clearance construct | supporting_markers | S3 renal Mg tranche | MIXED / HIGH | Preserve |
| Batch_3_Pass_3.json | inv_magnesium_low_total_body_magnesium_deficiency | signal_magnesium_low | magnesium | `fractional_excretion_magnesium` | Derived construct | supporting_markers | S3 | MIXED / HIGH | Preserve |
| Batch_6_Pass_3.json | inv_mcv_low_microcytosis_iron_deficiency | signal_mcv_low | mcv | `rbc_count` | Registry prerequisite | supporting_markers | SSOT for `rbc_count` | CONTENT / STANDARD | Preserve |
| Batch_7_Pass_3.json | inv_neutrophils_high_acute_bacterial_inflammatory_response | signal_neutrophils_high | neutrophils | supporting `lym` | Alias ambiguity (downstream of primary) | supporting_markers | S2 after `lym` resolution | MIXED / HIGH until `lym` fixed | Preserve |
| Batch_7_Pass_3.json | inv_neutrophils_low_marrow_suppression_or_drug_effect | signal_neutrophils_low | neutrophils | supporting `lym` | Alias ambiguity | supporting_markers | S2 | MIXED / HIGH until `lym` fixed | Preserve |
| Batch_4_Pass_3.json | inv_triglycerides_high_severe_hypertriglyceridemia_context | signal_triglycerides_high | triglycerides | `amylase` | Specialist analyte / pancreas-adjunct | supporting_markers | SSOT expansion | CONTENT / STANDARD | Preserve |
| Batch_4_Pass_3.json | inv_vitamin_d_high_vitamin_d_excess_context | signal_vitamin_d_high | vitamin_d | `parathyroid_hormone` | Missing SSOT PTH | supporting_markers | S1 | CONTENT / STANDARD | Preserve |
| Batch_4_Pass_3.json | inv_vitamin_d_low_vitamin_d_deficiency | signal_vitamin_d_low | vitamin_d | `parathyroid_hormone` | Missing SSOT PTH | supporting_markers | S1 | CONTENT / STANDARD | Preserve |
| Batch_7_Pass_3.json | inv_wbc_high_reactive_leukocytosis | signal_wbc_high | wbc | supporting `lym` (`wbc` primary maps via alias per KB-S52A) | Alias ambiguity in differential | supporting_markers | S2 | MIXED / HIGH until `lym` fixed | Preserve |
| Batch_7_Pass_3.json | inv_wbc_low_global_leukopenic_suppression | signal_wbc_low | wbc | supporting `lym` | Alias ambiguity | supporting_markers | S2 | MIXED / HIGH until `lym` fixed | Preserve |

**Source inspection note (method):** For each row, `primary_marker`, `supporting_markers`, and (where cited by KB-S52A) `hypotheses` / `contradiction_markers` / `override_rules` were checked in the corresponding `Batch_*_Pass_3.json` entry. KB-S52A remains the authoritative **unmapped ID** register; this audit classifies those IDs against KB-S52B remap + NA classes.

---

## 5. STOP conditions (prompt) — KB-S53 assessment

| # | Condition | Result |
|---|-----------|--------|
| 1 | Wave C list not derivable | **CLEAR** — enumerated in `translation_contract_v3_to_package_KB-S52B_v1.yaml` `wave_c_blocked_prerequisite.spec_ids` |
| 2 | Competing authority for blocker typing | **CLEAR** — KB-S52A + KB-S52B contracts cited; biomarker SSOT paths unchanged |
| 3 | Material contract inconsistency requiring mutation to proceed | **CLEAR** — classification uses existing LOCKED artefacts only |
| 4 | Audit requires repo edits to prove | **CLEAR** — markdown-only deliverable |
| 5 | Drift into contract redesign | **NOT TRIGGERED** |
| 6 | Drift into implementation | **NOT TRIGGERED** |

---

## 6. Acceptance criteria mapping (sprint prompt)

| # | Criterion | Evidence |
|---|-----------|----------|
| 1 | Every Wave C spec inventoried | §4 table — **46** rows |
| 2 | Named blocker class | §4 **Blocker class** column |
| 3 | Named blocker location | §4 **Blocker location** column |
| 4 | Proposed unblock path | §4 **Recommended unblock path** + §2 sequence |
| 5 | Expected eventual risk | §4 **Eventual fix risk** + Executive summary |
| 6 | Structural unblock vs regeneration | §3 + §4 **Regeneration** column |
| 7 | No source artifacts deleted / rewritten | KB-S53 produced **only** this file |
| 8–9 | No package / SSOT / validator / runtime edits | **No code or package changes** in KB-S53 |
| 10 | Bounded follow-on plan | §2 |

---

**KB-S53 complete.**  
*Next authority step:* human / GPT authors downstream sprint prompts per §2 tranches; Claude hardening per Automation Bus SOP v1.3.1 before any ingestion execution.
